VHL and cancer: The results presented here delineate molecular mechanisms by which HIFs mediate enhanced glutamate receptor signaling in Hep3B, 786-O, and RCC4 cancer cells through the direct, coordinate transcriptional activation of multiple genes encoding glutamate transporters and glutamate receptors in response to HIF activity resulting either from hypoxia or VHL loss-of-function.